Here, we present a case of a woman with LFS and therapy-refractory osteosarcoma with homozygous loss of cyclin dependent kinase inhibitor 2 A (CDKN2A) in the tumor cells. Here, CDKN2A is linked to Li-Fraumeni syndrome.